Skip to main content
. 2023 May 10;2023(5):CD014682. doi: 10.1002/14651858.CD014682.pub2

Sarzi Puttini 1988.

Study characteristics
Methods Design: parallel
Duration: 4 weeks
Assessment: baseline and post‐intervention
Country: Italy
Participants Pain condition: RA
Population: adults with RA and with or without depression
Minimum pain intensity: ≥ 50 on 0‐100 scale
Inclusion criteria
  • Classical or definite active RA, diagnosed according to the ARA criteria

  • Pain intensity ≥ 50 on 0‐100 scale


Exclusion criteria: NR
Total participants randomised: 60
Age in years (mean, SD): NR
Gender: 52/60 were female
Pain duration in years (mean, SD): NR
Interventions Placebo
  • n = 30

  • Inert


Dothiepin 75 mg
  • n = 30

  • TCA

  • Fixed dose

Outcomes Study provided no useable data
Missing data methods Completer analysis
Funding source NR
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Randomisation methods not specified
Allocation concealment (selection bias) Unclear risk Allocation methods not specified
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk Says matched dosing schedules but not other information given
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Self‐reported outcomes from participants but unsure of blinding
Incomplete outcome data (attrition bias)
All outcomes High risk Completer analysis only
Attrition
Total: 10/60 (16.7%)
Attrition per arm NR
Selective reporting (reporting bias) Unclear risk No protocol or trial registration found
Other bias Low risk No other sources of bias were identified